BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22354000)

  • 21. Silent cerebral infarct in sickle cell anemia patients of southern Turkey.
    Nafile Sayman E; Leblebİsatan G; Leblebisatan Ş; Bıçakcı YK; Kılınç Y; Barutçu A
    Turk J Med Sci; 2020 Dec; 50(8):1887-1893. PubMed ID: 32599969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity.
    Pegelow CH; Wang W; Granger S; Hsu LL; Vichinsky E; Moser FG; Bello J; Zimmerman RA; Adams RJ; Brambilla D;
    Arch Neurol; 2001 Dec; 58(12):2017-21. PubMed ID: 11735775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nocturnal hypertension associated with stroke and silent cerebral infarcts in children with sickle cell disease.
    Strumph K; Hafeman M; Ranabothu S; Gomes W; Benitez S; Kaskel F; Manwani D; Mahgerefteh J
    Pediatr Blood Cancer; 2021 May; 68(5):e28883. PubMed ID: 33405393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does TGFBR3 Polymorphism Increase the Risk of Silent Cerebral Infarction in Egyptian Children with Sickle Cell Disease?
    Hassab H; Hanafi M; Elbeheiry A; Hassan M; Chazli YE
    Indian J Pediatr; 2023 Feb; 90(2):146-152. PubMed ID: 35781614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.
    Thangarajh M; Yang G; Fuchs D; Ponisio MR; McKinstry RC; Jaju A; Noetzel MJ; Casella JF; Barron-Casella E; Hooper WC; Boulet SL; Bean CJ; Pyle ME; Payne AB; Driggers J; Trau HA; Vendt BA; Rodeghier M; DeBaun MR
    Br J Haematol; 2012 Nov; 159(3):352-9. PubMed ID: 22958163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward Automated Detection of Silent Cerebral Infarcts in Children and Young Adults With Sickle Cell Anemia.
    Chen Y; Wang Y; Phuah CL; Fields ME; Guilliams KP; Fellah S; Reis MN; Binkley MM; An H; Lee JM; McKinstry RC; Jordan LC; DeBaun MR; Ford AL
    Stroke; 2023 Aug; 54(8):2096-2104. PubMed ID: 37387218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of age, cerebral infarcts, vasculopathy and haemoglobin on cognitive function, in Tanzanian children with sickle cell anaemia.
    Jacob M; Stotesbury H; Kija E; Saunders D; Mtei RJ; Tutuba H; Masanu U; Kilonzo M; Kazema R; Hood AM; Kirkham F; Dimitriou D; Makani J
    Eur J Paediatr Neurol; 2022 Mar; 37():105-113. PubMed ID: 35182942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silent Infarcts, White Matter Integrity, and Oxygen Metabolic Stress in Young Adults With and Without Sickle Cell Trait.
    Wang Y; Guilliams KP; Fields ME; Fellah S; Binkley MM; Reis M; Vo KD; Chen Y; Ying C; Blinder M; King AA; Hulbert ML; An H; Lee JM; Ford AL
    Stroke; 2022 Sep; 53(9):2887-2895. PubMed ID: 35545940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
    Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes.
    Jordan LC; Roberts Williams DO; Rodeghier MJ; Covert Greene BV; Ponisio MR; Casella JF; McKinstry RC; Noetzel MJ; Kirkham FJ; Meier ER; Fuh B; McNaull M; Sarnaik S; Majumdar S; McCavit TL; DeBaun MR
    Am J Hematol; 2018 Jun; 93(6):760-768. PubMed ID: 29520844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.
    Pegelow CH; Macklin EA; Moser FG; Wang WC; Bello JA; Miller ST; Vichinsky EP; DeBaun MR; Guarini L; Zimmerman RA; Younkin DP; Gallagher DM; Kinney TR
    Blood; 2002 Apr; 99(8):3014-8. PubMed ID: 11929794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell Disease.
    Kija EN; Saunders DE; Munubhi E; Darekar A; Barker S; Cox TCS; Mango M; Soka D; Komba J; Nkya DA; Cox SE; Kirkham FJ; Newton CRJC
    Stroke; 2019 Jul; 50(7):1719-1726. PubMed ID: 31195937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography.
    Powars DR; Conti PS; Wong WY; Groncy P; Hyman C; Smith E; Ewing N; Keenan RN; Zee CS; Harold Y; Hiti AL; Teng EL; Chan LS
    Blood; 1999 Jan; 93(1):71-9. PubMed ID: 9864148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
    Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of the silent cerebral infarct transfusion (SIT) trial.
    Casella JF; King AA; Barton B; White DA; Noetzel MJ; Ichord RN; Terrill C; Hirtz D; McKinstry RC; Strouse JJ; Howard TH; Coates TD; Minniti CP; Campbell AD; Vendt BA; Lehmann H; Debaun MR
    Pediatr Hematol Oncol; 2010 Mar; 27(2):69-89. PubMed ID: 20201689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.
    Dowling MM; Noetzel MJ; Rodeghier MJ; Quinn CT; Hirtz DG; Ichord RN; Kwiatkowski JL; Roach ES; Kirkham FJ; Casella JF; DeBaun MR
    J Pediatr; 2014 May; 164(5):1175-1180.e1. PubMed ID: 24529619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia.
    Champlin G; Hwang SN; Heitzer A; Ding J; Jacola L; Estepp JH; Wang W; Ataga KI; Owens CL; Newman J; King AA; Davis R; Kang G; Hankins JS
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2473-2479. PubMed ID: 34407676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease.
    Quinn CT
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):438-43. PubMed ID: 25696891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.